Muscular Dystrophy 55 Patients of DMD, BMD & LGMD

Slides:



Advertisements
Similar presentations
MOEIN KADKHODAPOUR,AMIRHOSEIN HASHEMIAN,ALI ABAEIYAN
Advertisements

Muscular Dystrophy Kate DeAngelis AP Biology 1/6/09 Kate DeAngelis AP Biology 1/6/09 Charles DeAngelis:
Duchenne Muscular Dystrophy Sherri Garcia Muscular Dystrophy: Walk a Mile in Their Shoes CDC’s 2005 Science Ambassador Program.
Duchenne Muscular Dystrophy: Orthopaedic Management.
MUSCULOSKELETAL DISORDERS THE MUSCULOSKELETAL SYSTEM Bones and bone growth –Epiphyseal plates…bone growth occurs here and when these seal over, there.
Postural Screening Program. Background The Massachusetts Department of Public Health has promoted postural screening in schools since 1971 In 1980, regulation.
Muscular Dystrophy By: Jamie Wallace.
Merosin Deficient Congenital Muscular Dystrophy Cause and Diagnosis.
Duchenne Muscular Dystrophy
By Dr. MUKESH D. JAIN , MD AYURVEDA ACHARYA
D UCHENNE ’ S M USCULAR D YSTROPHY Kate Chipchase Vts teaching Feb 2012 ST2.
Muscular Dystrophy Dayna Ryan, PT, DPT Winter 2012.
Muscular Dystrophy By: Kaitlin Fleming Katie Sabatino Maggie Cacchione.
MUSCULAR DYSTROPHY By Jasmine DeLong. INHERITANCE Muscular dystrophy is a hereditary condition marked by progressive weakening and wasting of the muscles.
The Muscular System Structure Muscles have tissues that holds muscle cells together that provides elasticity. Muscle tissue also has many contractile.
Congestive Heart Failure (CHF)
Greyson P. Cole W. Corinne H.
Muscular dystrophy. By: Eric Rubio.
Jackson Friesth Period 5 Biology. The Origin of Muscular Dystrophy Muscular dystrophy is a recessive gene, that if passed down will cripple vital muscle.
Muscular Dystrophy. What it is… Muscular Dystrophy is a family of hereditary disease that cause progressive and steady muscle weakening. Duchenne and.
Duchenne Muscular Dystrophy
Commonly referred to as DMD The disease was first described by the Neapolitan physician Giovanni Semmola in 1834 and Gaetano Conte in 1836 DMD is named.
Diseases of musculoskeletal system
kyphosis lordosis and scoliosis
Muscular Dystrophy By Jessica Wang.
M USCULAR D YSTROPHY By: Collin Lowe. C AUSES Muscular Dystrophy is inherited in an X-linked recessive pattern, meaning that the mutated gene that causes.
Duchenne Muscular Dystrophy
(DMD) Duchenne Muscular Dystrophy. History of DMD It was first described by a french neurologist named Guillaume Benjamin Amand Duchenne in Previous.
Spine Curvature Disorders
Ashley Webb. Definition Muscular dystrophy (MD) is a group of rare inherited muscle diseases in which muscle fibers are unusually susceptible to damage.
MUSCULAR DYSTROPHY BY ALBERT DIPPEL, ISAAC MOODIE, NYLEAH MORRIS-BROWN.
Common Facts 4 DMD is a recessive, genetic disorder Most common X chromosome linked disorder Disorder of the motor neuron, neuromuscular.
OF THE MUSCULAR SYSTEM Diseases and Disorders. Anabolic Steroids Anabolic steroids are man-made substances related to male sex hormones. Medical uses.
Duchenne Muscular Dystrophy Jared Rubenstein. What Causes DMD? Caused by a mutation in a gene, called the DMD gene that can be inherited in families in.
Skeletal and Muscular. Brittni Parrish..
Primary muscle disease Commonest is Duchene muscular dystrophy (DMD) Presence in early childhood Genetic disease Absence or mutation of gene responsible.
Cerebral Palsy Meagan Ricks. What is it? 0 Cerebral Palsy is a group of disorders which can affect the brain and nervous system. 0 Oftentimes, this can.
Treatment goals of treatment relieve pain, prevent or reduce stress on the discs, and maintain normal function ranges from conservative therapies to surgical.
Treatment. Therapy Goal: – to maximize the functional use of limbs and ambulation – to reduce the risk of contractures – to help the patient in attaining.
Huntington's Disease By: Walter Gerring and Seth Little.
Duchenne Muscular Dystrophy By: Andrea Ortega. Chromosome Graphic.
Scoliosis by Hannah & Tylyn
DYSTROPHY MUSCULAR Isamar Villacrés Carlos Carlosama.
© McGraw-Hill Higher Education. All Rights Reserved Chapter Five.
Renal Complications Associated with Diabetes By Gabriella Benavides FNP-BC.
Hydrotherapy In Child With Progressive Muscular Dystrophy (Case Study)
Duchenne's Muscular Dystrophy By: Timothy Taggart & Mark Miville-Deschenes.
Chapter ?? 23 Osteoporosis Nichols and Pavlovic C H A P T E R.
Energy For Muscles Glucose + Oxygen = Energy to contract muscles and produce heat Glucose: stored in the muscles as glycogen Oxygen: used to burn glucose.
Genetics and its relation to neuromuscular diseases
Conditions in Occupational Therapy 5th edition Ben J
MUSCULAR DYSTROPHY B Y : N A Y B E L P E R E Z.
Pathology of the Muscular System.
Spasticity ; Muscle Hypertonicity
Chapter 13 Muscles, Bones, and Nerves
Statistics Facts Causes Symptoms Treatments
Muscle Dystrophy Jon Durrani, DO Attending Neurologist
By: Kelli Novak & Katelyn Thompson
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Flatfoot in Adults.
Duchenne’s muscular dystrophy
Lesson 2: Diseases and Disorders
Anthony Ravasio Health 9 April 09, 2017
Unit 4 Notes: Common Skeletal & Muscular Disorders.
Daniel Li and L.J. Wei Harvard University
Bent Male Organ Problems: Get the 411 on Peyronie’s Disease and How to Treat It
Presentation transcript:

Muscular Dystrophy 55 Patients of DMD, BMD & LGMD Evaluation of Mamsagni Rasayana [MGR] in 55 Patients of DMD, BMD & LGMD Mukesh Jain, AMDS India The Ayush Samiti Bhilai CG

Muscular Dystrophy Incurable Genetic disease The dysfunction of Vata & Dhatvagnis is the main pathology. Muscle degeneration due to progressive diminishing of Mamsagni along with aggravation of Vata element. Symptoms & Signs: # Large calf muscles # Walking on the toes # Using the hands to rise from a sitting position, called Gower's sign # Progressive muscle deterioration, starting with the muscles nearest the hips # Curvature of the spine # Enlargement of the heart muscle # intellectual impairment # Breathing Difficulty.

Muscular Dystrophy Weakness Tightness Hypertrophy Lack of movement Spine curvature Poor lung functions Intellectual impairment Heart Problems Muscle weakness & Tightness, Hypertrophy,

Mamsagat Vata Vyadhi

Treatment, Help & Monitoring The major goal of early treatment is to keep the ability to walk as long as possible. Pawan Muktasana, Stretching exercises and using braces at night help avoid the tightening of tendons. Surgery can be used to release tight tendons. Mamsagni Rasayana is promising molecule. It is an ayurvedic dietary supplement and is safe and superior than Prednisone for long term management of muscular dystrophies.

Ayurvedic Treatment Panch Karma & Rasayana treatments have shown promising protective effects on NMD. These therapies and remedies help in the regeneration of dhatus because they are capable to balance the Doshas and Agnis. TMP Swedana procedure is effective to stabilize Vata dominant Sarcolemmal membrane defect.

Care through Research Clinic Bhilai AMDS India Study involving Mamsagni Rasayana along with TMP & Yogic Support yielded mixed results in 55 boys of DMD, BMD & LGMD

& treated during March 1999 & Sep 2004. 28 DMD , 19 BMD 8 LMGD boys . Over 100 cases of Muscular dystrophies were enrolled at Panch Karma Clinic of Central Medical Institute, Bhilai & treated during March 1999 & Sep 2004. 28 DMD , 19 BMD 8 LMGD boys All the Dystrophy boys were subjected to 2 weeks Panch karma procedures before administration of oral Mamsagni Rasayana along with Yogic support for 6 months.

Observation & Results: It was observed that degeneration of muscle fibers were arrested after 6 weeks of administration of Mamsagni Rasayana. This was presumed on the basis of reduced CK level in blood and functional improvement such as (i) Weight loss, (ii) Decrease in walking difficulty and (iii) Decrease in the severity of contractures and scoliosis. However DMD boys have shown very slow progress.

RESULT ANALYSIS : DMD (BARTHEL -SANJEEVAN SCALE) MARKED RELIEF 42% MODERATE 21% MILD RELIEF 36.8%

RESULT ANALYSIS

Average Observations Improvement in Functional Ability visible after 6 weeks of Administration of MGR Presumption : Reduced CPK level, weight loss, Decrease in Walking difficulty. Decrease in the Severity of Contractures and Scoliosis.

Average Decrement in 24 Weeks 45% -2.8 Kg. -2800 (IU) 10% BLOOD CK CONTRACTURE SEVERITY WT LOSS

Quality of Life Improvement 90% 60% 40% SELF CONFIDENCE ENDURANCE FUNCTIONAL

A Case Of DMD PATIENT BEFORE TREATMENT PATIENT AFTER TREATMENT

EFFECT OF TMP IN DMD BEFORE REATMENT AFTER TREATMENT

Effect of Mamsagni Rasayana BEFORE TREATMENT AFTER TREATMENT

Functional Improvement in a DMD BEFORE TREATMENT AFTER 12 WEEKS

Improvement in DMD Boy BEFORE TREATMENT AFTER TREATMENT